Inhibitory Effects of HIV-1-infected Stromal Cell Layers on the Production of Myeloid Progenitor Cells in Human Long-term Bone Marrow Cultures
Overview
Affiliations
This report presents the results of studies using long-term bone marrow cultures (LTBMC) of human bone marrow cells to investigate the effect of HIV-1 on in vitro hematopoiesis. Confluent stromal cell layers established from human bone marrow cells were irradiated to eliminate residual hematopoietic progenitor cells and exposed to HIV-1ADA or to HIV-1IIIB, monocytotropic and lymphocytotropic strains of HIV-1, respectively. A productive infection did not develop in cultures exposed to HIV-1IIIB but did for cultures exposed to HIV-1ADA as there was a progressive increase in HIV-1 p24 antigen. Stromal cell layers infected with HIV-1ADA were also cocultured with autologous CD34+ bone marrow cells. Four days, 1, 2, and 3 weeks later, the number of colony-forming units granulocyte/macrophage (CFU-GM) in non- and HIV-infected LTBMC was determined. The number of CFU-GM increased during the first week in both non- and HIV-infected LTBMC. One week after the coculture of CD34+ cells with stromal cell layers infected with HIV-1ADA, the number of CFU-GM in six out of eight experiments was reduced compared to noninfected control LTBMC. In those six experiments, the number of CFU-GM was 53 +/- 6% standard error of the mean (SEM) of the number in noninfected LTBMC. A reduced number of CFU-GM was observed in the nonadherent fraction of HIV-infected LTBMC for at least 2 weeks. These results demonstrate that some cells in the stromal cell layers of LTBMC were targets for HIV-1 and that HIV-infected stromal cell layers suppressed or delayed the production of CFU-GM.
Associated factors and prognostic implications of neutropenia in individuals with HIV/AIDS.
Li P, Lv X, Shen H, Fang J, Wei M, Liu X Virol J. 2025; 22(1):6.
PMID: 39789626 PMC: 11721557. DOI: 10.1186/s12985-025-02624-x.
Neutropenia during HIV infection: adverse consequences and remedies.
Shi X, Sims M, Hanna M, Xie M, Gulick P, Zheng Y Int Rev Immunol. 2014; 33(6):511-36.
PMID: 24654626 PMC: 4873957. DOI: 10.3109/08830185.2014.893301.
Iron supplementation for reducing morbidity and mortality in children with HIV.
Adetifa I, Okomo U Cochrane Database Syst Rev. 2009; (1):CD006736.
PMID: 19160298 PMC: 7388901. DOI: 10.1002/14651858.CD006736.pub2.
Bahner I, Kearns K, Hao Q, Smogorzewska E, Kohn D J Virol. 1996; 70(7):4352-60.
PMID: 8676458 PMC: 190368. DOI: 10.1128/JVI.70.7.4352-4360.1996.